[1]Bosch FX, Ribes J, Diaz M, et al.Primary liver cancer:worldwide incidence and trends[J].Gastroenterology, 2004, 127 (Suppl 1) :s5-16.
|
[2]Williams R J.Biochemical individuality the Basis for theGenetotrophic Concept[M].New York:John Wiley&Sons, Inc, 1956:195.
|
[3]中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志, 2009, 25 (2) :83-92.
|
[4]Shimozawa N, Hanazaki K.Longterm prognosis after hepaticresection for small hepatocellular carcinoma[J].J Am CollSurg, 2004, 198 (3) :356-365.
|
[5]Zhou XD, Tang ZY, Ma ZC, et al.Surgery for large primaryliver cancer more than 10 cm in diameter[J].J Cancer ResClin Oncol, 2003, 129 (9) :543-548.
|
[6]Llovet JM, Fuster J, Bruix J.Intention-to-treat analysis ofsurgical treatment for early hepatocellular carcinoma:Resectionversus transplantation[J].Hepatology, 1999, 30 (6) :1434-1440.
|
[7]Figueras J, Ibanez L, Ramos E, et al.Selection criteria forliver transplantation in early stage hepatocellular carcinomawith cirrhosis:results of a multicenter study[J].Liver Transpl, 2001, 7 (10) :877-883.
|
[8]Lau WY, Leung TW, Yu SC, et al.Percutaneous local ablativetherapy for hepatocellular carcinoma:a review and look intothe future[J].Ann Surg, 2003, 237 (2) :171-179.
|
[9]Josep M, Llovet, Sergio Ricci, et al.Sorafenib in AdvancedHepatocellular Carcinoma[J].N ENGL J med, 2008:359 (4) :378-390.
|
[1] | Xiaoting LI, Bobin HU, Hongyu LIU, Chao JIN, Cailian CAI, Keshan WANG, Yanchun WEI, Jianning JIANG, Minghua SU. Effectiveness of fibrosis-4 versus aspartate aminotransferase-to-platelet ratio index in evaluating liver fibrosis degree in patients with chronic HBV infection[J]. Journal of Clinical Hepatology, 2024, 40(12): 2424-2429. doi: 10.12449/JCH241212 |
[2] | Long HUANG, Hongqian LIANG, Aoli REN, Minghua SU, Bobin HU, Qingmei LI, Tumei SU, Qianbing YIN, Yanfei FENG, Jianning JIANG. Diagnostic value of serum extra-spindle pole-like protein 1 in the progression of hepatitis B virus-related liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1785-1789. doi: 10.12449/JCH240911 |
[3] | Lu HUANG, Lijian LU. Value of MRI biliary score and liver/muscle ratio in evaluating the pathological grade of liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(4): 720-725. doi: 10.12449/JCH240413 |
[4] | Zhou GuangDe, Zhao JingMin. Pathological features of liver fibrosis/cirrhosis caused by different factors[J]. Journal of Clinical Hepatology, 2016, 32(6): 1086-1091. doi: 10.3969/j.issn.1001-5256.2016.06.013 |
[5] | Li Jing, Liu ZhiQuan, Lu YuFeng, Li YuXiao, Li BingShun. Analysis of correlations of age with liver pathological change and HBV DNA level in chronic HBV infection patients with normal ALT and mild ALT elevation[J]. Journal of Clinical Hepatology, 2015, 31(4): 537-540. doi: 10.3969/j.issn.1001-5256.2015.04.015 |
[6] | Zhang Hong, Zou HuaiBin, Mi YuQiang, Liu YongGang. The relationship between HBV genotype and liver biopsy outcome of chronic HBV carriers[J]. Journal of Clinical Hepatology, 2008, 24(6): 413-414. |
[7] | Ge WenSong, Yao DingKang, Zhu Liang. Preliminary study on proteomic patterns in hepatic tissue to identify HBV related hepatic firbrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 357-359. |
[8] | Wu FengTing, Lu: QiJun. Clinical relationships between cccDNA in sera with HBVDNA, YMDD mutants and hepatitis B relapse[J]. Journal of Clinical Hepatology, 2007, 23(5): 342-344. |
[10] | Zhang LiJie, Wang TaiLing, Wang XinXin, Meng Xin, Zhao JingMin, Song ChenChao, Sun Lin, Zhang ShiJie, Li JunQiang, Jin RongHua. The pathological study of chronic HBsAg carriers and inactive HBV infectious state[J]. Journal of Clinical Hepatology, 2007, 23(5): 337-339. |
[11] | Ding Hong, Lu ZhongHua, Jiang XiangHu. The relationship between the liver function and contents of serum HBVDNA and hepatic pathology in patiens with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2006, 22(3): 173-174. |
[13] | Li Qin, Ou XiaoJuan, Li Jia, Jia JiDong, Wang BaoEn. The contrast study of serum liver fibrosis indexes and liver pathology[J]. Journal of Clinical Hepatology, 2004, 20(3): 155-156. |
[15] | Ma HongBo, Lang ZhenWei, Jin Rui, Huang Chun, Duan ZhongPing, Jin RongHua, Lu: FuJing, Luo Gang, Li JingYing. Comparison analysis of the clinic parameter and the pathology in the patients with chronic hepatitis[J]. Journal of Clinical Hepatology, 2003, 19(3): 161-163. |
[16] | Chen RanFeng, Chen GuoJun, Huang XiaoWen, Dong ZhangLin, Zhu Xian. Correlation between HBV DNA expression and hepatic fibrosis[J]. Journal of Clinical Hepatology, 2002, 18(6): 354-355. |
[17] | Gu ShengWang, Zhang Lian, Feng XiaoRong, Peng JiLi, Hou JinLin, Lu QiaoSheng, Zhu YouFu, Luo KangXian. A study of clinical and pathological diagnosis of 1023 patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2001, 17(1): 41-42. |
[18] | Gu ShengWang, Jiang XiaoJing, He HaiTang, Luo KangXian. Pathological study of TTV related hepatitis established in situ hybridization[J]. Journal of Clinical Hepatology, 2000, 16(4): 237-239. |